Fellowships

We equip fellows with the skills needed to carry out research relevant to the NHS. Another of the Academy's major drivers is to lead promising individuals to longer term prestigious external fellowships from leading Government and charity funding bodies.

Our Fellowship Scheme has already awarded 25 fellowships across a broad range of disciplines, from genetic medicine and paediatrics, to inflammation and patient engagement.

The fellowships are:

• Dr Claire Bonshek (Early life identification of genetic and metabolomic signatures in primordial growth disorders for use as biomarkers of poor growth potential)
• Dr James McCaffrey (Epigenetics in childhood steroid sensitive nephrotic syndrome)
• Dr Katherine Martin (Defining future targets for anti fibrotic therapy in liver fibrosis)
• Dr Sophia Khan (Prediction of cardiovascular risk in relation to growth, growth factors and metabolic profiles in children of South Asian (Pakistani) and European origin)
• Dr Lucy Higgins (Predicting fetal compromise using novel biomarkers in women perceiving reduced fetal movements)
• Dr Shruti Garg (The behavioural phenotype in neurofibromatosis type 1 - characterisation and preparation for a treatment trial)
• Dr Reza Aghamohammadzadeh (The influence of perivascular adipose tissue on vascular tone in health and obesity)
• Dr Varinder Athwal (SOX9 in liver fibrosis: translating molecular genetics toward the clinic)
• Dr Siddharth Banka (Genetics of metabolic disorders with haematological manifestations)
• Dr Rafik Bedair (Evaluation of myocardial dysfunction, the microcirculation and cytokine profile in hypotensive sepsis and the role of enoximone therapy)
• Dr Emma Burkitt Wright (Investigation of RAS-MAPK pathway signalling in neurocardiofaciocutaneous syndromes: identification of therapeutic strategies)
• Dr Hassan Fadavi (Corneal confocal microscopy: A non-invasive surrogate for diabetic neuropathy)
• Alisha Gibson  (Participating in a pharmacogenetic clinical trial: Views and information needs of adolescents, parents, health professionals and clinical trialists)
• Maryam Jangani (Novel pharmacokinetic approach for the use of glucocorticoids in the treatment of inflammatory disease)
• Emma Jenkinson (Genes involved in hearing and endocrine development)
• Dr Rachel Jennings (Defining early lineage differentiation in the developing human pancreas)
• Dr Theodora Nikalaidou (Identification and evaluation of novel serum biomarkers for heart failure using metabolomics-an initial step towards a holistc view of heart failure)
• Dr Mary O’Driscoll (Agenesis of the corpus callosum: A clinical and genetic analysis)
• Dr Ben Parker (Effects of biological agents on inflammation and vascular function in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE): inflammation reduction or drug effect?)
• Dr Arvind Ponnusamy (Prenylation as a therapeutic target for vascular calcification)
• Dr Louise Porter (Brittle Cornea Syndrome: Molecular characterisation of a multisystem disorder)
• Dr John Reynolds (Vitamin D Deficiency, Disease Activity and Cardiovascular Health in Systemic Lupus Erythematosus)
• Ana Sergijenko (Development of clinical transplant protocol for lentiviral mediated autologous stem cell gene therapy of Sanfilippo disease in Manchester)
• Dr Cathy Symonds(Developing imaging biomarkers for depression and responsiveness to new glutamatergic therapies)
• Deirdre Thajam (The role of placental multi-drug resistance proteins (MRDP) in determinining fetal susceptibility of drugs of abuse)

To find out more about our Fellowship Scheme and to be kept up to date on future fellowship calls please email Neil.hanley@manchester.ac.uk